DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20185356

Study of fibrinogen levels in patients of acute stroke

Vinod Khandait, Pratik Barai

Abstract


Background: Stroke is a disease of paramount public health significance. The role of plasma fibrinogen in determining incidence and severity of stroke has been postulated time and again. Present study was undertaken to determine the correlation between mean plasma fibrinogen level and infarct volume on CT scan in patients with acute stroke.

Methods: Present prospective observational study of two years duration at our tertiary care government centre entailed enrollment and radiological assessment (CT scan/MRI) of 50 consecutive patients with first-ever stroke admitted within 24 h after stroke onset along with measurement of their plasma fibrinogen levels at admission.

Results: Thirty (60%) cases reported ischemic stroke while haemorrhagic stroke was observed in 20 (40%) cases. The mean fibrinogen levels in ischemic (584±62mg/dl) and haemorrhagic stroke (52±28mg/dl) were found to be significantly higher (p<0.05) than normal range of (200-400mg/dl). The mean infarct volume in patients with ischemic stroke was 62.79±9.51cm3 while mean plasma fibrinogen level was 584±62mg/dl. There was significant correlation between infarct volume and fibrinogen levels (r coefficient =0.61; p<0.05). The fibrinogen levels in patients who died was insignificantly higher as compared to patients who survived.

Conclusions: We report significantly higher than normal mean fibrinogen levels in ischemic and haemorrhagic stroke with the correlation between infarct volume and fibrinogen levels being significant in ischemic stroke. Limited mortality numbers probably didn’t allow the present study to reach the level of significance. Similar studies with larger sample size are recommended.


Keywords


Hemorrhagic stroke, Ischemic stroke, Plasma fibrinogen level

Full Text:

PDF

References


Murray C, Lopez A. Cambridge, MA. Harvard University Press; 1996. Global health statistics: A compendium of incidence, prevalence and mortality estimates for over 200 conditions. Available at: www.hup.harvard.edu/catalog.php?isbn=9780674354494.

Strong K, Mathers C, Bonita R. Preventing stroke: Saving lives around the world. Lancet Neurol. 2007;6:182-7.

Kamalakannan S, Gudlavalleti ASV, Gudlavalleti VSM, Goenka S, Kuper H. Incidence and prevalence of stroke in India: A systematic review. Ind J Med Rese. 2017;146(2):175-85.

Strong K, Mathers C. The global burden of stroke. In: Mohr JP, Grotta JC, Wolf PA, Moskowitz MA, Mayberg MR, Von Kummer R, editors. Stroke: Pathophysiology, Diagnosis and Management. 5th ed. Philadelphia, PA: Elsevier; 2011:279-289.

Mistry P, Chawla KP, Rai HP, Jaiswal P. Plasma fibrinogen levels in stroke. J postgrad Med. 1990;36:1-4.

Varoqlu AO, Kuyucu M, Demir R, Acemoglu H, Can I, Akcay F. Prognostic values of lesion volume and biochemical markers in ischemic and hemorrhagic stroke: a stereological and clinical study. Int J Neurosci. 2009;119:2206-18.

Munro JM, Costran RS. The pathogenesis of atherosclerosis: Atherogenesis and inflammation. Lab Invest. 1988;58:249-61.

Montaner J, Perea -Gainza M, Delgado P, Ribo M, Chacon P, Rosell A, et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke. 2008;39:2280-7.

WHO MONICA Project Investigators. The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease). J Clin Epidemiol. 1988;41:105-14.

Swarowska M, Janowska A, Polczak A, Klimkowicz-Mrowiec A, Pera J, Slowik A, et al. The sustained increase of plasma fibrinogen during ischemic stroke predicts worse outcome independently of baseline fibrinogen level. Inflammation. 2014 Aug 1;37(4):1142-7.

Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol. 1957;17(4):237-46.

Sacco RL, Wolf PA, Kannel, McNamara. Survival and recurrence following stroke. The Framingham Study. Stroke. 1982;13:290-5.

Kiyohara Y, Kubo M, Kato I, Tanizaki Y, Tanaka K, Okubo K, et al. Ten-year prognosis of stroke and risk factors for death in a Japanese community. The Hisayama Study. Stroke. 2003;34:2343-8.

Anderson CS, Jamrozik KD, Broadhurst RJ, Stewart-Wynne EG. Predicting survival for 1 year among different subtypes of stroke. Results from the Perth Community Stroke Study. Stroke. 1994;25:1935-44.

Bamford J, Dennis M, Sandercock P, Burn J, Warlow C. The frequency causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry. 1990;53:824-9.

Nayak SD, Nair M, Radhakrishnan K, Sarma PS. Ischaemic stroke in the young adult: clinical features, risk factors and outcome. Natl Med J India. 1997 May-Jun;10(3):107-12.

Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and Ischemic Strokes Compared. Stroke Severity, Mortality, and Risk Factors. Stroke. 2009;40:2068-72.

Azam R, Khan M, Arshed A. Correlation between Mean Plasma Fibrinogen Level and Mean Lesion Volume on CT scan in Acute Ischemic Stroke. PJMHS. Oct-Dec 2015;9(4).

Tripathi M, Vibha D. Stroke in young in India. Stroke Research and Treatment. 2011;11:368-69.

Lipska K, Sylaja PN, Sarma PS, Thankappan KR, Kutty VR, Vasan RS, et al. Risk factors for acute ischaemic stroke in young adults in South India. J Neurol Neurosur Psychiat. 2007;78:959-63.

Arnold M, Halpern M, Meier N, Fischer U, Haefeli T, Kappeler L. Age dependent differences in demographics, risk factors, co-morbidity, etiology, management and clinical outcome of acute ischeamic stroke. J Neurol. 2008;255:1503-7.

Narayanaswamy M, Ravi K, Nagarjun BR. A Comparative Study of Selective Indicator Profiles in Patients with Ischemic Stroke and Hemorrhagic Stroke. J Evi Med Healthca. 2015 February;2(6):655-62.